Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ProQR (PRQR)
NASDAQ:PRQR
Holding PRQR?
Track your performance easily
PRQR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.61 - $4.62
Previous Close$2.83
Volume2.93M
Average Volume (3M)1.48M
Market Cap
$292.07M
Enterprise Value$187.56M
Total Cash (Recent Filing)€118.92M
Total Debt (Recent Filing)€19.73M
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Feb 26, 2025EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.32
Shares Outstanding81,354,592
10 Day Avg. Volume769,154
30 Day Avg. Volume1,478,737
Standard Deviation0.35
R-Squared0.00125
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)4.84
Price to Sales (P/S)21.69
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.00Price Target Upside264.37% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
ProQR News
PremiumCompany Announcements
ProQR Secures $8.1 Million for Rett Syndrome RNA Therapy
PremiumCompany Announcements
ProQR Strengthens RNA Editing Team with Key Appointment
PremiumCompany Announcements
ProQR Highlights RNA Innovations in Upcoming EventPremiumCompany Announcements
ProQR Therapeutics Highlights Q3 2024 Financial ResultsOwnership Overview
―
Insiders
0.65% Mutual Funds
14.54% Other Institutional Investors
84.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PRQR FAQ
What was ProQR’s price range in the past 12 months?
ProQR lowest stock price was $1.61 and its highest was $4.62 in the past 12 months.
What is ProQR’s market cap?
Currently, no data Available
When is ProQR’s upcoming earnings report date?
ProQR’s upcoming earnings report date is Feb 26, 2025 which is in 67 days.
How were ProQR’s earnings last quarter?
ProQR released its earnings results on Nov 07, 2024. The company reported -$0.105 earnings per share for the quarter, beating the consensus estimate of -$0.111 by $0.006.
Is ProQR overvalued?
According to Wall Street analysts ProQR’s price is currently Undervalued.
Does ProQR pay dividends?
ProQR does not currently pay dividends.
What is ProQR’s EPS estimate?
ProQR’s EPS estimate is -$0.1.
How many shares outstanding does ProQR have?
ProQR has 103,203,735 shares outstanding.
What happened to ProQR’s price movement after its last earnings report?
ProQR reported an EPS of -$0.105 in its last earnings report, beating expectations of -$0.111. Following the earnings report the stock price went down -1.923%.
Which hedge fund is a major shareholder of ProQR?
Among the largest hedge funds holding ProQR’s share is Gilder Gagnon Howe & Co LLC.. It holds ProQR’s shares valued at N/A.
---
ProQR Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.00 (264.37% Upside)
$9.00 (264.37% Upside)
Hedge Fund Trend
Decreased
By 97.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.2%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.72%
12-Months-Change
Fundamentals
Return on Equity
-67.62%
Trailing 12-Months
Asset Growth
-20.70%
Trailing 12-Months
Company Description
ProQR
ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.
---
PRQR Stock 12 Month Forecast
Average Price Target
$9.00
▲(264.37% Upside)
Technical Analysis
Best Analysts Covering PRQR
1 Year
1 Year Success Rate
14/24 ratings generated profit
1 Year Average Return
-3.64%
reiterated a buy rating 9 days ago
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of -3.64% per trade.
---